Shared Decision Making Tools for Cardiovascular Prevention
(SDM4IP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Cardiovascular (CV) disease is the #1 cause of premature mortality and substantial morbidity in the U.S. Despite clinical guidelines, most clinical interventions are implemented in people at relatively lower CV risk, and few among people at the highest risk. Shared decision making (SDM) can mitigate the risk-treatment paradox by reducing risk blindness and lack of fit of the preventive regimen, but the adoption of SDM in routine clinical care is incomplete. This study addresses SDM adoption of a CV prevention SDM tool in three health systems.
Who Is on the Research Team?
Jennifer Ridgeway, PhD
Principal Investigator
Mayo Clinic
Victor Montori, MD
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for adults aged 40-75 who are at risk of cardiovascular disease but haven't had a heart attack or stroke. It's open to those with or without diabetes receiving care at certain clinics. Clinicians from these practices can also join. People who don't speak English or have cognitive issues affecting consent are excluded.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Implementation
Health systems are assigned to usual care and then move into active implementation of the CV Prevention Choice tool
Maintenance
All health systems move to maintenance implementation to ensure the CV Prevention Choice tool is part of routine practice
Follow-up
Participants are monitored for the effectiveness and adoption of the SDM tool in routine practice
What Are the Treatments Tested in This Trial?
Interventions
- CV Prevention Choice Tool
- Implementation Facilitation Strategies
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor